Bert Jacquemyn

Suggest Changes
  • Citations Per Year
Learn More
OBJECTIVES TMC310911 is a novel HIV type-1 (HIV-1) protease inhibitor with broad in vitro antiviral activity. In this phase 2a, open-label randomized study, the antiviral activity, pharmacokinetics,(More)
  • 1